Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

作者：Bruno Sangro, Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, Shukui Qin, Zhenggang Ren, Stephen L. Chan, Yasuaki Arai, Jeong Heo, Anh Mai, Jose Escobar, Yamil Alonso Lopez Chuken, Jung-Hwan Yoon, Won Young Tak, Valeriy V Breder, Tanita Suttichaimongkol, Mohamed Bouattour, Shi-Ming Lin, Jean-Marie Peron, Quang T Nguyen, Lünan Yan, Chang-Fang Chiu, Florinda A Santos, Anil Veluvolu, Satheesh Chiradoni Thungappa, Marco Matos, Magdalena Żotkiewicz, Stephanie I. Udoye, John F. Kurland, G. Cohen, Riccardo Lencioni, Kathia Cristina Abdalla, Manon Allaire, Gustavo R. Alves, Luís Carlos Moreira Antunes, Eric Assénat, Sérgio Jobim Azevedo, Rafael Barreto, Muhammad Shaalan Beg, Glaucio Bertollo, Jean‐Frédéric Blanc, Mohamed Bouattour, Rakesh Reddy Boya, Valery Breder, Jean–Pierre Bronowicki, Manoch Buranachokphaisan, Adam M. Burgoyne, Stephen L. Chan, Ting‐Tsung Chang, Yee Chao, Eric Chen, Xiaoming Chen, Chang-Fang Chiu, Minsig Choi, SUNGHEE CHOI, Natalie G. Coburn, Luis Contreras, Farshid Dayyani, Thomas Decaens, Arunee Dechaphunkul, Maria del Consuelo Diaz, Anouk Dev, Jamille Dutra, Melissa Eastgate, Jose Escobar, Bassam Estfan, Vittorio Ferrari, Anne-Claire Frin, Sandip Ganguly, Ranga Raman Ganta, Shanzhi Gu, Yabing Guo, Atsushi Hagihara, Jeong Heo, Chih‐Hung Hsu, Jimmy Hwang, Yoshitaka Inaba, Shikha Jain, D. Jonker, Shruti Kate, Shruti Kate, Naoya Kato, Tomokazu Kawaoka, Kwong‐Ming Kee, Seung Up Kim, Kiyohide Kioka, Hironori Koga, Masatoshi Kudo, Hidekatsu Kuroda, Phuong Uyen Le, Han-chu Lee, Joon Hyeok Lee, Teng-Yu Lee, Dongliang Li, Hailiang Li, Wei Li, Xiao Li, Cheng-Yao Lin, Shi-Ming Lin, Yamil Lopez, Ligong Lu, Anh Mai, K. G Mamontov, Kunlatida Maneenil, Aleksei Manikhas, Gianluca Masi, Ana Matilla, Marco Matos, Vincenzo Mazzaferro, Zhiqiang Meng, Prabrajya Narayan Mohapatra, Vladimir Moiseyenko, Alejandro Molina, J.L. Montero, Manabu Morimoto, Daniel Motola, Guzel Mukhametshina, Hayato Nakagawa, Jean‐Charles Nault, Quang Nguyen, Amanda Nicoll, María Fernanda Noriega, Takuji Okusaka, Hideki Onishi, Vikas Sureshchand Ostwal, Jie Pan, Joong‐Won Park, Ankit D. Patel, Rodrigo Pérez, Jean-Marie Peron, Shukui Qin, Francisco Ramirez, Zhenggang Ren, Stuart K. Roberts, Julie Rowe, Y. Runglodvatana, Bruno Sangro, Bruno Sangro, Florinda Santos, Ravi Kumar Saxena, Guoliang Shao, Anthony F. Shields, Oksana Shirokova, Aditya Shreenivas, Michele Sisani, V. Yu. Skoropad, Simone I. Strasser, Thatthan Suksombooncharoen, Tanita Suttichaimongkol, Wai Meng David Tai, Won Young Tak, Gao‐Jun Teng, Satheesh Chiradoni Thungappa, Nguyen Tran, Son Hong Trinh, Kaoru Tsuchiya, Kunihiko Tsuji, Idoia Ugarteburu, Teerapat Ungtrakul, Gina M. Vaccaro, Anil Veluvolu, Tuoi T. N. Vo, Yoshiyuki Wada, Alva B. Weir, Aibing Xu, Lvnan Yan, Jung-Hwan Yoon, Oleg Zarubenkov, Yongyi Zeng, Yonghong Zhang, Ming Zhao, Xin Zheng, Ling Zhu, Xu Zhu · 发表于：The Lancet · 年份：2025 · DOI：10.1016/s0140-6736(24)02551-0 · 被引用次数：263 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cholangiocarcinoma and Gallbladder Cancer Studies、Organ Transplantation Techniques and Outcomes